Accessibility settings

Published on in Vol 6 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/69800, first published .
Close-up of a hand typing on a laptop keyboard, focusing on fingertips and keys.

Harnessing AI and Quantum Computing for Revolutionizing Drug Discovery and Approval Processes: Case Example for Collagen Toxicity

Harnessing AI and Quantum Computing for Revolutionizing Drug Discovery and Approval Processes: Case Example for Collagen Toxicity

Authors of this article:

David Melvin Braga1 Author Orcid Image ;   Bharat Rawal2 Author Orcid Image

Journals

  1. Das U. Transforming Precision Medicine through Generative AI: Advanced Architectures and Tailored Therapeutic Design for Patient‐Specific Drug Discovery. ChemistrySelect 2025;10(36) View
  2. Matarèse B. Quantum and Artificial Intelligence in Drugs and Pharmaceutics. BioChem 2026;6(1):2 View
  3. Sargolzaei M, Nikoofard H. AI-driven quantum chemical exploration of multi-target synthetic opioid analogs for enhanced therapeutic profiles. Journal of Computer-Aided Molecular Design 2026;40(1) View
  4. Devadas R, T S. Quantum technologies in clinical medicine: a systematic cross-domain synthesis and translational readiness taxonomy. Journal of King Saud University Computer and Information Sciences 2026;38(7) View

Books/Policy Documents

  1. Islam Khan M, Sojib N, Karim M, Roosan D. Quantum Informatics for Novel Therapeutics. View
  2. Takawira B. Architecting Strategic Business Transformation Through Data-Driven Systems. View
  3. Patel T. AI, Nanobiotechnology, and the Future of Precision Antibiotics. View